On Friday, Mersana Therapeutics Inc (NASDAQ: MRSN) was 18.94% up from the session before settling in for the closing price of $0.26. A 52-week range for MRSN has been $0.26 – $3.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 12314.39% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -29.24%. With a float of $85.81 million, this company’s outstanding shares have now reached $115.65 million.
In an organization with 102 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 56.37%, operating margin of -181.09%, and the pretax margin is -169.82%.
Mersana Therapeutics Inc (MRSN) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mersana Therapeutics Inc stocks. The insider ownership of Mersana Therapeutics Inc is 31.15%, while institutional ownership is 54.68%. The most recent insider transaction that took place on Jan 16 ’25, was worth 2,061. In this transaction VP, Chief Accounting Officer of this company sold 3,554 shares at a rate of $0.58, taking the stock ownership to the 57,519 shares. Before that another transaction happened on Jan 16 ’25, when Company’s Director sold 8,637 for $0.58, making the entire transaction worth $5,009. This insider now owns 168,041 shares in total.
Mersana Therapeutics Inc (MRSN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -29.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -13.09% during the next five years compared to 2.74% growth over the previous five years of trading.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
You can see what Mersana Therapeutics Inc (MRSN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.57, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Let’s dig in a bit further. During the last 5-days, its volume was 2.9 million. That was inferior than the volume of 5.48 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 24.07%. Additionally, its Average True Range was 0.05.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 2.02%, which indicates a significant decrease from 27.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 123.33% in the past 14 days, which was lower than the 142.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4880, while its 200-day Moving Average is $1.4559. However, in the short run, Mersana Therapeutics Inc’s stock first resistance to watch stands at $0.3275. Second resistance stands at $0.3440. The third major resistance level sits at $0.3755. If the price goes on to break the first support level at $0.2795, it is likely to go to the next support level at $0.2480. Assuming the price breaks the second support level, the third support level stands at $0.2315.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
There are 124,631K outstanding shares of the company, which has a market capitalization of 38.75 million. As of now, sales total 40,500 K while income totals -69,190 K. Its latest quarter income was 16,360 K while its last quarter net income were -14,120 K.
